© 2018 LabShares Newton LLC

AffyImmune

AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer with the goal of realizing the revolutionary potential of cancer immunotherapy.

 

The company's lead compound is designed to treat patients with advanced thyroid cancers that do not respond to other agents.